Protease activated receptor 2: a new target for IBS treatment.
D000818:Animals; D041981:Gastrointestinal Tract / Q000378:metabolism; D006801:Humans; D007413:Intestinal Mucosa / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D043183:Irritable Bowel Syndrome / Q000188:drug therapy*; D010447:Peptide Hydrolases / Q000378:metabolism; D010539:Permeability; D044464:Receptor, PAR-2 / Q000187:drug effects* / Q000378:metabolism
D044464:Receptor, PAR-2; D010447:Peptide Hydrolases